Key Takeaways
- Novo Nordisk (NVO) shares plummeted 18% after the pharmaceutical giant's sales outlook for the year missed analyst estimates, signaling anticipated declines in sales and profit growth amidst pricing pressures and patent expirations for key drugs like Wegovy and Ozempic.
- Watches of Switzerland Group (WOSG) upgraded its full-year outlook, driven by a robust rebound in demand for high-end timepieces, particularly in the crucial U.S. market.
- Spain's services sector showed a softer expansion in January, with the HCOB Services PMI falling to 53.5 from 57.1, significantly missing the estimated 56.8, and the Composite PMI also declining to 52.9, indicating a slowdown in economic activity.
- Airbus (AIR) is targeting 2029 for a concept version of its "mothership" A400M cargo plane, highlighting long-term innovation in the aerospace sector.
- EU Trade Commissioner Maroš Šefčovič is scheduled to meet Australia's Trade Minister next week in Brussels, with discussions expected to focus on critical minerals and the revival of a stalled trade deal.
Major market movements were observed today as Novo Nordisk (NVO) saw its shares tumble by 18% following a disappointing sales outlook for the current fiscal year. The pharmaceutical company anticipates a decline in both sales and operating profit growth, ranging between 5% and 13% at constant exchange rates for 2026. This forecast was below analyst expectations and is attributed to lower realized prices in the U.S. market and the loss of exclusivity for its blockbuster drugs Wegovy and Ozempic in certain international markets. The company's full-year 2025 net sales of DKK309.06 billion also fell short of analyst estimates of DKK346.97 billion.
In contrast, luxury retailer Watches of Switzerland Group (WOSG) provided a more optimistic update, upgrading its outlook for the current year. The positive revision comes as demand for high-end timepieces experiences a significant rebound. The company reported strong strategic and operational progress, with a notable improvement in performance during the second half of its fiscal year. Demand for key luxury brands, including those with registration of interest lists, remains robust and continues to outstrip supply in both the U.S. and UK markets.
Meanwhile, economic data from Spain presented a more subdued picture. The HCOB Services PMI for January registered 53.5, a decrease from December's 57.1 and falling short of the estimated 56.8. Similarly, the HCOB Composite PMI also declined to 52.9 from 55.6, missing the forecast of 55.4. These figures suggest a slower rate of expansion within Spain's services sector, indicating a potential moderation in overall economic growth.
In the aerospace sector, Airbus (AIR) announced its ambitious plan to deliver a concept version of its "mothership" A400M cargo plane by 2029. This initiative underscores the company's focus on innovation and future capabilities in military transport aircraft.
On the geopolitical and trade front, EU Trade Commissioner Maroš Šefčovič is set to meet with Australia's Trade Minister in Brussels next week. The discussions are expected to cover critical minerals, where the EU is keen to secure supply, and efforts to revive a comprehensive trade deal between the two entities, which stalled in 2023. The EU is exploring various investment options in Australian critical minerals projects, including equity stakes and long-term off-take agreements.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.